54 results
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
7 May 24
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering of Common Stock
5:28pm
structured in a manner reasonably designed to comply with the state, federal and foreign Health Care Laws applicable to the Company’s and the Subsidiaries … ’ respective businesses, and the Company and the Subsidiaries are in compliance with such applicable Health Care Laws, except where the failure to do
D
SLNO
Soleno Therapeutics Inc
4 Oct 23
$59.99 mm in equity / options / securities to be acquired, sold $59.99 mm, 14 investors
10:36am
Services
Oil & Gas
Other Energy
Health Care
Biotechnology
Health Insurance
Hospitals & Physicians
Pharmaceuticals
Other Health Care
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
with the state, federal and foreign Health Care Laws applicable to the Company’s and the Subsidiaries’ respective businesses, and the Company … and the Subsidiaries are in compliance with such applicable Health Care Laws, except where the failure to do so could not reasonably be expected to have
424B5
SLNO
Soleno Therapeutics Inc
29 Sep 23
Prospectus supplement for primary offering
4:51pm
course of federal or state health care legislation or foreign regulations relating to the marketing, pricing and reimbursement of pharmaceutical products … or conceal an obligation to pay money to the federal government;
S-42
HIPAA established the federal offense of health care fraud, which among other things
424B5
asnrz27oyj1yg
27 Sep 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-1.1
kt3i n5fic5
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
424B5
3af14fg8o
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
y61znacal7ldhnhdo97
28 Mar 22
Prospectus supplement for primary offering
4:53pm
8-K
EX-1.1
9lya wg1thim
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm
424B5
zlfd 5fo4793p9t16
25 Jun 20
Prospectus supplement for primary offering
4:01pm